Parameter
| Biomarker | COMP | Full name | serum chondrocyte oligomeric matrix protein | Molecular Type | chondroitin |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Early diagnosis and post-traumatic cartilage injury monitoring | ||
| Disease | Osteoarthritis (OA) | Disease Subtypes | / | ||
| Organ | Joint (Cartilage) | Test Sample / Technology Platform | Serum (ELISA, immunoturbidimetry) | ||
| Pathobiological Mechanisms | Abnormal cartilage repair after trauma, with COMP released into the bloodstream and elevated levels indicating increased risk of cartilage injury | ||||
| Clinical Availability Status | Clinical trials | ||||
| Notes and Dynamics | atients with elevated serum COMP levels within 1 month post-trauma have a 2-fold increased risk of developing osteoarthritis within 2 years. | ||||